Oracle, Proteus Address Patient Adherence Data
Oracle and Proteus have integrated Proteus Digital Health Feedback System with Oracle Health Sciences InForm.
Oracle and Proteus Integrate Proteus Digital Health Feedback System with Oracle Health Sciences InForm to Help Increase Clinical Trial Accuracy
Oracle Health Sciences InForm electronic data capture platform utilizes Proteus solution, enabling greater accuracy in measuring medication adherence during clinical trials.
Bristol-Myers Squibb Commits to Global Impact Partnership and Site Advocacy Group
INC Research First CRO to Launch Site Advocacy Group to Enhance the Clinical Research Process
Record Number of Medicines for Rare Diseases Recommended for Approval in 2014
Number of medicines with new active substances continues to increase.
Director General of EFPIA: “Pan-European HTA necessary”
Director General of EFPIA argued passionately in favour of the homogenization of European HTA bodies and regulation, during a recent interview
EFPIA Boss Renews Support for Health Technology Assessment
The Director General of EFPIA has spoken out strongly in favor of the homogenization of European health technology assessment bodies and regulation.
Qualcomm Announces Strategic Collaboration with Novartis to Optimize Global Clinical Trials
Novartis selects Qualcomm Life and its 2net technology to digitize its clinical trials
EMA Recommends Record Number of Medicines for Rare Diseases
In 2014, the European Medicines Agency (EMA) recommended the highest number of orphan designated medicines for marketing authorization in a year.
Novartis Selects Qualcomm Lifes 2net Tech to Digitize Clinical Trials
Qualcomm announced that its subsidiary, Qualcomm Life, has been selected by Novartis as a global digital health collaborator for its Trials of The Future program.
Radiant Sage Releases RadClinica Version 3.0
Radiant Sage announced the release of its Clinical Trial Management System RadClinica™ version 3.0
Clinical Trial Management Solution Now Offers a Robust and Intuitive System with Real-time Information to Organize a Trial
Synchrogenix Acquires ClinGenuity
Certaa announced that its regulatory and medical consultancy, Synchrogenix, has acquired ClinGenuity.
Synchrogenix, Certara’s Regulatory and Medical Writing Consultancy, Acquires ClinGenuity
Deal provides Synchrogenix withproprietary technology, expert staff, and new capabilities to become the dominant player in life science regulatory and medical writing
Applied Clinical Trials to Sponsor Events at Partnerships
Applied Clinical Trials is pleased to announce our sponsorship of Partnerships in Clinical Trials' Partnership Hall of Famer Award, as well as its Clinical Operations Optimization track.
Dragging European Clinical Trials Rules into Operation
The entry into force of the new EU clinical trials regulation last June is really little more than a virtual event.
Mapi Group Acquires Select Services of Optum Life Sciences
Mapi has completed the acquisition of select Optum Life Sciences services.
Mapi Completes the Acquisition of Select Life Sciences Services
Mapi Group completes the acquisition of select Life Sciences services.
Françoise Meunier Prepares for New Role at EORTC
Françoise Meunier will become Director of Special Projects for the European Organization for Research and Treatment of Cancer starting April 1, 2015.
The EORTC Board cordially invites you to a Plenary Session in honor of Francoise Meunier
At the Crowne Plaza Brussels - Le Palace on 12 March 2015 at 16:00
PPD and SNBL Announce Japanese Clinical Development Joint Venture and Additional Collaborations
PPD and Shin Nippon Biomedical Laboratories Ltd. announced an agreement to form a joint venture.
PPD and SNBL Announce Japanese Joint Venture
EMA Management Board: highlights of December 2014 meeting
The Board adopts EMA work program 2015-2016
EMA Sets Out Priorities and Predictions for 2015-2016
The Management Board of the European Medicines Agency (EMA) has outlined its priorities for the next two years.
Michael J. Rosenberg, Innovator in Clinical Research, Dies at 66
Michael J. Rosenberg died on December 8 in an accident while en route to a meeting at the Food and Drug Administration.
Compassionate Use Debate Heats Up
Patient access to critical experimental medicines continues to grab public attention, as states enact “Right-to-Try” laws and Congress eyes establishing a national policy to provide not-yet-approved therapies to terminally ill patients.
Biosimilar Development Moves Forward at FDA
FDA has scheduled a public meeting in early January to assess and weigh the data on the first US application for a biosimilar therapy.
Europe Says Goodbye to Another Type of Transparency
After nearly five years of argument, the European Union's proposal to update its transparency directive for medicines has been dropped.
EMA Investigates Potential of Adaptive Pathways
As of November 2014, the European Medicines Agency (EMA) had received and assessed 29 applications as part of its pilot project on adaptive pathways, formerly known as adaptive licensing.
FDA Moves to Streamline Pediatric Drug Development
Building on more than a decade of initiatives to spur pediatric labeling on drugs and biologics, regulatory authorities are bolstering incentives for sponsors to develop more information faster on the use of medicines in children.
